Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
Status:
Recruiting
Trial end date:
2023-12-08
Target enrollment:
Participant gender:
Summary
The study aims to investigate the safety, tolerability, efficacy, pharmacodynamics (PD),
pharmacokinetics (PK), and immunogenicity of efgartigimod compared to placebo in participants
with post-COVID-19 postural orthostatic tachycardia syndrome (POTS) (post-COVID-19 POTS).